From GHRH to IGF-1 and downstream: Clinical phenotypes and biological mechanisms

Pediatric Endocrinology Reviews

Volumn 9, Issue SUPPL. 1, 2011, Pages 529-534

  Pfäffle, Roland ^a   Kies, Wieland ^a   Klammt, Jürgen ^a  

^a Leipzig Medical School ^*  (Germany)

Author keywords

IGF i mutations; IGHD type1; Type 1 B

Indexed keywords

GONADORELIN; GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; TRANSCRIPTION FACTOR SOX3; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; SOMATOMEDIN C RECEPTOR;

AMINO ACID SUBSTITUTION; AUTOSOMAL RECESSIVE INHERITANCE; CONFERENCE PAPER; DELAYED PUBERTY; GENE CLUSTER; GENE DELETION; GENE INACTIVATION; GENETIC DISORDER; GENETIC VARIABILITY; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; IMMUNOASSAY; INTRAUTERINE GROWTH RETARDATION; MICROGNATHIA; MISSENSE MUTATION; MOLECULAR GENETICS; NONSENSE MUTATION; PHENOTYPE; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PROTEIN BLOOD LEVEL; PSYCHOMOTOR RETARDATION; SMALL FOR DATE INFANT; TISSUE CULTURE; ALGORITHM; CHILD; CLASSIFICATION; GENETICS; METABOLISM; MUTATION; NEWBORN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ALGORITHMS; CHILD; GROWTH DISORDERS; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MUTATION; PHENOTYPE; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION;

EID: 84859238416     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Rona RJ, Altman DG, National study of health and growth: standards of attained height, weight and triceps skinfold in English children 5 to 11 years old. Ann Hum Biol 1977;4:501-523 (Pubitemid 8235226)
2. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M, Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-353.
3. Corneli G, Vivenza D, Prodam F, Di Dio G, Vottero A, Rapa A, Bellone S,Bernasconi S, Bona G, Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.J Endocrinol Invest 2008;31:689-693
4. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson IC, Beddington RS, Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001;10:39-45 (Pubitemid 32051566)
5. Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, le Bouc Y, Epelbaum J, Amselem S, Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin Endocrinol Metab 2009;94:4334-4341
6. Solomon NM, Ross SA, Forrest SM, Thomas PQ, Morgan T, Belsky JL, Hol FA,Karnes PS, Hopwood NJ, Myers SE, Tan AS, Warne GL, Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 2007;44:75
7. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M, Otonkoski T, Martinez-Barbera JP, Thomas PQ, Robinson IC, Lovell-Badge R, Woodward KJ, Dattani MT, Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005;76:833-849 (Pubitemid 40563104)
8. Illig R, Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH). J Clin Endocrinol Metab 1970;31:679-688
9. Phillips JA, 3rd, Hjelle BL, Seeburg PH, Zachmann M, Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci U S A 1981;78:6372-6375 (Pubitemid 12179714)
10. Laron Z, Kelijman M, Pertzelan A, Keret R, Shoffner JM, Parks JS, Human growth hormone gene deletion without antibody formation or growth arrest during treatment-a new disease entity? Isr J Med Sci 1985;21:999-1006 (Pubitemid 16157464)
11. Mullis PE, Genetics of growth hormone deficiency. Endocrinol Metab Clin North Am 2007;36:17-36
12. Mullis PE, Biological determinants of responsiveness to growth hormone: pharmacogenomics and personalized medicine. Endocr Dev 2010;18:67-82
13. Perez Jurado LA, Phillips JA, 3rd, Francke U, Exclusion of growth hormone (GH) releasing hormone gene mutations in familial isolated GH deficiency by linkage and single strand conformation analysis. J Clin Endocrinol Metab 1994;78:622-628 (Pubitemid 24083302)
14. Mayo KE, Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol 1992;6:1734-1744
15. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE, GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 1993;4:227-232 (Pubitemid 23205169)
16. Wajnrajch MP, Gertner JM, Sokoloff AS, Ten I, Harbison MD, Netchine I, Maheshwari HG, Goldstein DB, Amselem S, Baumann G, Leibel RL, Haplotype analysis of the growth hormone releasing hormone receptor locus in three apparently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor. Am J Med Genet A 2003; 120:77-83 (Pubitemid 37063836)
17. Baumann G, Mutations in the growth hormone releasing hormone receptor: a new form of dwarfism in humans. Growth Horm IGF Res 1999;9SupplB:24-29;29-30
18. Alatzoglou KS, Dattani MT, Genetic causes and treatment of isolated growth hormone deficiency-an update. Nat Rev Endocrinol 2010;6:562-576
19. Alba M, Salvatori R, Familial Growth Hormone Deficiency and Mutations in the GHRH Receptor Gene. Vitam Horm 2004;69:209-220 (Pubitemid 39753690)
20. Espigares R, Martin de Lara I, Ruiz-Cabello F, Ortega L, Ferrandez Longas A, Argente J, Salvatori R, Phenotypic analysis and growth response to different growth hormone treatment schedules in two siblings with an inactivating mutation in the growth hormone-releasing hormone receptor gene. J Pediatr Endocrinol Metab 2004;17:793-800
21. Godi M, Mellone S, Petri A, Arrigo T, Bardelli C, Corrado L, Bellone S, Prodam F, Momigliano-Richiardi P, Bona G, Giordano M, A recurrent signal peptide mutation in the growth hormone releasing hormone receptor with defective translocation to the celt surface and isolated growth hormone deficiency. J Clin Endocrinol Metab 2009;94:3939-3947
22. Inoue H, Kangawa N, Kinouchi A, Sakamoto Y, Kimura C, Horikawa R, Shigematsu Y, Itakura M, Ogata T, Fujieda K, Identification and functional analysis of novel human growth hormone-releasing hormone receptor (GHRHR) gene mutations in Japanese subjects with short stature. Clin Endocrinol (Oxf) 2011;74:223-233
23. Oliveira HA, Salvatori R, Krauss MP, Oliveira CR, Silva PR, Aguiar-Oliveira MH Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene. Eur J Endocrinol 2003;148:427-432 (Pubitemid 36527413)
24. Salvatori R, Aguiar-Oliveira MH, Monte LV, Hedges L, Santos NL, Pereira RM, Phillips JA, Detection of a recurring mutation in the human growth hormone-releasing hormone receptor gene. Clin Endocrinol (Oxf) 2002;57:77-80 (Pubitemid 34785887)
25. Siklar Z, Berberoglu M, Legendre M, Amselem S, Evliyaoglu O, Hacihamdioglu B, Erdeve SS, Ocal G, Two Siblings with Isolated GH Deficiency Due to Loss-of-Function Mutation in the GHRHR Gene: Successful Treatment with Growth Hormone Despite Late Admission and Severe Growth Retardation. J Clin Res Pediatr, Endocrinol 2010;2:164-167
26. Alatzoglou KS, Turton JP, Kelberman D, Clayton PE, Mehta A, Buchanan C, Aylwin S, Crowne EC, Christesen HT, Hertel NT, Trainer PJ, Savage MO, Raza J, Banerjee K, Sinha SK, Ten S, Mushtaq T, Brauner R, Cheetham TD, Hindmarsh PC, Mullis PE, Dattani MT, Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency. J Clin Endocrinol Metab 2009;94:3191-3199
27. Cogan JD, Phillips JA, 3rd, Schenkman SS, Milner RD, Sakati N, Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomelic protein. J Clin Endocrinol Metab 1994;79:1261-1265 (Pubitemid 24369833)
28. Perez Jurado LA, Argente J, Molecular basis of familial growth hormone deficiency. Horm Res 1994;42:189-197 (Pubitemid 24336147)
29. Wagner JK, Eble A, Hindmarsh PC, Mullis PE, Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 1998;43:105-110 (Pubitemid 28069175)
30. Kamijo T, Hayashi Y, Shimatsu A, Kinoshita E, Yoshimoto M, Ogawa M, Seo H, Mutations in intron 3 of GH-1 gene associated with isolated GH deficiency type II in three Japanese families. Clin Endocrinol (Oxf) 1999;51:355-360 (Pubitemid 29439056)
31. Binder G, Keller E, Mix M, Massa GG, Stokvis-Brantsma WH, Wit JM, Ranke MB, Isolated GH deficiency with dominant inheritance: new mutations, new insights. J Clin Endocrinol Metab 2001;86:3877-3881 (Pubitemid 32755992)
32. Binder G, Ranke MB, Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 1995;80:1247-1252
33. Hess O, Hujeirat Y, Wajnrajch MP, Allon-Shalev S, Zadik Z, Lavi I Tenenbaum-Rakover Y, Variable phenotypes in familial isolated growth hormone deficiency caused by a G6664A mutation in the GH-1 gene. J Clin Endocrinol Metab 2007;92:4387-4393 (Pubitemid 350074761)
34. McCarthy EM, Phillips JA, 3rd,Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet 1998;7:1491-1496
35. Mullis PE, Deladoey J, Dannies PS, New GH-1 gene mutations: expanding the spectrum of causes of isolated growth hormone deficiency. J Pediatr Endocrinol Metab 2002;15(Suppl5):1301-1310
36. Petkovic V, Eble A, Pandey AV, Betta M, Mella P, Fluck CE, Buzi F, Mullis PE, A novel GH-1 gene mutation (GH-P59L) causes partial GH deficiency type II combined with bioinactive GH syndrome. Growth Horm IGF Res 2011;21:160-166
37. Petkovic V, Godi M, Pandey AV, Lochmatter D, Buchanan CR, Dattani MT, Eble A, Fluck CE, Mullis PE, Growth hormone (GH) deficiency type II: a novel GH-1 gene mutation (GH-R178H) affecting secretion and action. J Clin Endocrinol Metab 2010;95:731-739
38. Takahashi I, Takahashi T, Komatsu M, Sato T, Takada G, An exonic mutation of the GH-1 gene causing familial isolated growth hormone deficiency type II. Clin Genet 2002;61:222-225 (Pubitemid 36372637)
39. Mullis PE, Robinson IC, Salemi S, Eble A, Besson A, Vuissoz JM, Deladoey J, Simon D, Czernichow P, Binder G, Isolated autosomal dominant growth hormone deficiency: an evolving pituitary deficit? A multicenter follow-up study. J Clin Endocrinol Metab 2005;90:2089-2096 (Pubitemid 40586244)
40. Lee MS, Wajnrajch MP, Kim SS, Plotnick LP, Wang J, Gertner JM, Leibel RL, Dannies PS, Autosomal dominant growth hormone (GH) deficiency type II:the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology 2000;141:883-890 (Pubitemid 32260431)
41. Hayashi Y, Yamamoto M, Ohmori S, Kamijo T, Ogawa M, Seo H, Inhibition of growth hormone (GH) secretion by a mutant GH-I gene product in neuroendocrine cells containing secretory granules: an implication for isolated GH deficiency inherited in an autosomal dominant manner. J Clin Endocrinol Metab 1999;84:2134-2139 (Pubitemid 30647045)
42. Petkovic V, Godi M, Lochmatter D, Eble A, Fluck CE, Robinson IC, Mullis PE, Growth hormone (GH)-releasing hormone increases the expression of the dominant negative GH isoform in cases of isolated GH deficiency due to GH splice-site mutations. Endocrinology 2010;151:2650-2658
43. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf1) and type 1 IGF receptor (Igf1r). Cell 1993;75:59-72 (Pubitemid 23306021)
44. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ, Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996;335:1363-1367 (Pubitemid 26360455)
45. Walenkamp MJ, Karperien M, Pereira AM, Hilhorst-Hofstee Y, van Doom J, Chen JW, Mohan S, Denley A, Forbes B, van Duyvenvoorde HA, van Thiel SW, Sluimers CA, Bax JJ, de Laat JA, Breuning MB, Romijn JA, Wit JM, Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab 2005;90:2855-2864 (Pubitemid 40686336)
46. Netchine I, Azzi S, Houang M, Seurin D, Perin L, Ricort JM, Daubas C, Legay C, Mester J, Herich R, Godeau F, Le Bouc Y, Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab 2009;94:3913-3921
47. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfäffle R, Raile K, Seidel B, Smith RJ Chernausek SD, IGF-I Receptor Mutations Resulting in Intrauterine and Postnatal Growth Retardation. New England Journal of Medicine 2003;349:2211-2222 (Pubitemid 37485137)
48. Wallborn T, Wüller S, Klammt J, Kruis T, Kratzsch J, Schmidt G, Schlicke M, Müller E, Schmitz van de Leur H, Kiess W, Pfäffle R, A Heterozygous Mutation of the Insulin-Like Growth Factor-I Receptor Causes Retention of the Nascent Protein in the Endoplasmic Reticulum and Results in Intrauterine and Postnatal Growth Retardation. Journal of Clinical Endocrinology & Metabolism 2010;95:2316-2324
49. Kruis T, Klammt J, Galli-Tsinopoulou A, Wallborn T, Schlicke M, Muller E, Kratzsch J, Korner A, Odeh R, Kiess W, Pfäffle R, Heterozygous mutation within a kinase-conserved motif of the insulin-like growth factor I receptor causes intrauterine and postnatal growth retardation. J Clin Endocrinol Metab 2010;95:1137-1142
50. Kawashima Y, Kanzaki S, Yang F, Kinoshita T, Hanaki K, Nagaishi J-i, Ohtsuka Y, Hisatome I, Ninomoya H, Nanba E, Fukushima T, Takahashi S-I, Mutation at Cleavage Site of Insulin-Like Growth Factor Receptor in a Short-Stature Child Born with Intrauterine Growth Retardation. Journal of Clinical Endocrinology & Metabolism 2005;90:4679-4687 (Pubitemid 41159358)
51. Inagaki K, Tiulpakov A, Rubtsov P, Sverdlova P, Peterkova V, Yakar S, Terekhov S, LeRoith D, A Familial Insulin-Like Growth Factor-l Receptor Mutant Leads to Short Stature: Clinical and Biochemical Characterization. Journal of Clinical Endocrinology & Metabolism 2007;92:1542-1548 (Pubitemid 46556437)
52. Fang P, Schwartz ID, Johnson BD, Derr MA, Roberts CT, Hwa V,Rosenfeld RG, Familial Short Stature Caused by Haploinsufficiency of the Insulin-Like Growth Factorl Receptor due to Nonsense-Mediated Messenger Ribonucleic Acid Decay.Journal of Clinical Endocrinology & Metabolism 2009;94:1740-1747
53. Ester WA, van Duyvenvoorde HA, de Wit CC, Broekman AJ, Ruivenkamp CA, Govaerts LC, Wit JM, Hokken-Koelega AC, Losekoot M, Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype. J Clin Endocrinol Metab 2009;94:4717-4727
54. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD, IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003;349:2211-2222 (Pubitemid 37485137)
55. Klammt J, Kiess W, Pfaffle R, IGF1R mutations as cause of SGA. Best Pract Res Clin Endocrinol Metab 2011;25:191-206